Vitamin A, cancer treatment and prevention: The new role of cellular retinol binding proteins

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Doldo, Elena ^a   Costanza, Gaetana ^a   Agostinelli, Sara ^a   Tarquini, Chiara ^a   Ferlosio, Amedeo ^a   Arcuri, Gaetano ^a   Passeri, Daniela ^a   Scioli, Maria Giovanna ^a   Orlandi, Augusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN; CHAPERONE; RETINOIC ACID BINDING PROTEIN; RETINOID; RETINOL; RETINOL DERIVATIVE; MESSENGER RNA; RETINOIC ACID;

BONE GROWTH; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PREVENTION; CANCER THERAPY; CELL DIFFERENTIATION; DRUG BIOAVAILABILITY; ESTERIFICATION; HUMAN; NASOPHARYNX CANCER; NONHUMAN; OVARY CANCER; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; WOUND HEALING; APOPTOSIS; BIOSYNTHESIS; CELL PROLIFERATION; CYTOSOL; DIET THERAPY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR;

ANIMALIA;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RETINOL-BINDING PROTEINS, CELLULAR; RNA, MESSENGER; TRETINOIN; VITAMIN A;

EID: 84927145379     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/624627     Document Type: Review

References (143)

1. M. E. Gottesman, L. Quadro, and W. S. Blaner, "Studies of vitamin Ametabolism inmouse model systems", Bio Essays, vol. 23, no. 5, pp. 409-419, 2001.
2. C. Folli, V. Calderone, S. Ottonello et al., "Identification, retinoid binding, and X-ray analysis of a human retinol-binding protein", Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3710-3715, 2001.
3. R. Kawaguchi, J. Yu, J. Honda et al., "A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A", Science, vol. 315, no. 5813, pp. 820-825, 2007.
4. N. Matt, C. K. Schmidt, V. Dupé et al., "Contribution of cellular retinol-binding protein type 1 to retinol metabolism during mouse development", Developmental Dynamics, vol. 233, no. 1, pp. 167-176, 2005.
5. M. Donovan, B. Olofsson, A.-L. Gustafson, L. Dencker, and U. Eriksson, "The cellular retinoic acid binding proteins", The Journal of Steroid Biochemistry and Molecular Biology, vol. 53, no. 1-6, pp. 459-465, 1995.
6. P. Chambon, "A decade of molecular biology of retinoic acid receptors", The FASEB Journal, vol. 10, no. 9, pp. 940-954, 1996.
7. B. C. Das, P. Thapa, R. Karki et al., "Retinoic acid signalingpathways in development and diseases", Bioorganic & Medicinal Chemistry, vol. 22, no. 2, pp. 673-683, 2014.
8. A. L. Fields, D. R. Soprano, and K. J. Soprano, "Retinoids in biological control and cancer", Journal of Cellular Biochemistry, vol. 102, no. 4, pp. 886-898, 2007.
9. C. S. Beeman and J. E. Kronmiller, "Temporal distribution of endogenous retinoids in the embryonic mouse mandible", Archives of Oral Biology, vol. 39, no. 9, pp. 733-739, 1994.
10. M. H. Zile, "Function of vitamin A in vertebrate embryonic development", The Journal of Nutrition, vol. 131, no. 3, pp. 705-708, 2001.
11. F. A. Mic, A. Molotkov, D. M. Benbrook, and G. Duester, "Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis", Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7135-7140, 2003.
12. A. Molotkov, N. B. Ghyselinck, P. Chambon, and G. Duester, "Opposing actions of cellular retinol-binding protein and alcohol dehydrogenase control the balance between retinol storage and degradation", Biochemical Journal, vol. 383, no. 2, pp. 295-302, 2004.
13. G. Dirami, G. D. Massaro, L. B. Cierch, U. S. Ryan, P. R. Reczek, and D. Massaro, "Lung retinol storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation", The American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 286, no. 2, pp. L249-L256, 2004.
14. J. Rossant, R. Zirngibl, D. Cado, M. Shago, and V. Giguère, "Expression of a retinoic acid response element-hsplac Z transgene defines specific domains of transcriptional activity during mouse embryogenesis", Genes & Development, vol. 5, no. 8, pp. 1333-1344, 1991.
15. R. W. Yost, E. H. Harrison, and A. C. Ross, "Esterification by rat liver microsomes of retinol bound to cellular retinol-binding protein", Journal of Biological Chemistry, vol. 263, no. 35, pp. 18693-18701, 1988.
16. G. de Carlo Massaro, D. Massaro, and P. Chambon, "Retinoic acid receptor-α regulates pulmonary alveolus formation in mice after, but not during, perinatal period", American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 284, no. 2, pp. L431-L433, 2003.
17. G. D. Massaro, D. Massaro, W. Y. Chan et al., "Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli.", Physiol Genomics, vol. 4, no. 1, pp. 51-57, 2000.
18. L. Tannous-Khuri, P. Hillemanns, N. Rajan, T. C. Wright, and D. A. Talmage, "Expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat cervical epithelium is regulated by endocrine stimuli during normal squamous metaplasia", The American Journal of Pathology, vol. 144, no. 1, pp. 148-159, 1994.
19. A. J. Tyson-Capper, D. M. W. Cork, E. Wesley, E. A. Shiells, and A. D. Loughney, "Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy", Molecular Human Reproduction, vol. 12, no. 11, pp. 695-701, 2006.
20. K. Subbaramaiah, P. A. Cole, and A. J. Dannenberg, "Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB binding protein/p300-dependent and -independent mechanisms", Cancer Research, vol. 62, no. 9, pp. 2522-2530, 2002.
21. J. W. Streb and J. M. Miano, "Retinoids: pleiotropic agents of therapy for vascular diseases?" Current Drug Targets. Cardiovascular and Haematological Disorders, vol. 3, no. 1, pp. 31-57, 2003.
22. A. Orlandi, A. Francesconi, D. Cocchia, A. Corsini, and L. G. Spagnoli, "Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro implications for the evolution of experimental intimal thickening", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 7, pp. 1118-1123, 2001.
23. A. Orlandi, P. Ropraz, and G. Gabbiani, "Proliferative activity and α-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-α1 and heparin", Experimental Cell Research, vol. 214, no. 2, pp. 528-536, 1994.
24. A. C. Gidlöf, P. Ocaya, P. S. Olofsson, H. Törmä, and A. Sirsjö, "Differences in retinol metabolism and proliferative response between neointimal and medial smooth muscle cells", Journal of Vascular Research, vol. 43, no. 4, pp. 392-398, 2006.
25. M. Koga and H. Ogasawara, "Induction of hepatocyte mitosis in intact adult rat by interleukin-1α and interleukin-6", Life Sciences, vol. 49, no. 17, pp. 1263-1270, 1991.
26. L. G. Spagnoli, A. Orlandi, A. Mauriello et al., "Aging and atherosclerosis in the rabbit, 1: distribution, prevalence and mosphology of atherosclerotic lesions", Atherosclerosis, vol. 89, no. 1, pp. 11-24, 1991.
27. A. Orlandi, A. Francesconi, S. Clément, P. Ropraz, L. Giusto Spagnoli, and G. Gabbiani, "High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation", Virchows Archiv, vol. 441, no. 1, pp. 31-40, 2002.
28. A. Orlandi, A. Francesconi, A. Ferlosio et al., "Propionyl-Lcarnitine prevents age-related myocardial remodeling in the rabbit", Journal of Cardiovascular Pharmacology, vol. 50, no. 2, pp. 168-175, 2007.
29. P. Neuville, Z.-Q. Yan, A. Gidlöf et al., "Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RAR α-dependent signaling pathway", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 6, pp. 1430-1436, 1999.
30. A. Niemann-Jönsson, M. P. S. Ares, Z.-Q. Yan et al., "Increased rate of apoptosis in intimal arterial smoothmuscle cells through endogenous activation of TNF receptors", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 12, pp. 1909-1914, 2001.
31. C. L. Seidel, "Cellular heterogeneity of the vascular tunica media: implications for vessel wall repair", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 1868-1871, 1997.
32. R. M. Niles, "Signaling pathways in retinoid chemoprevention and treatment of cancer", Mutation Research, vol. 555, no. 1-2, pp. 81-96, 2004.
33. L. Altucci and H. Gronemeyer, "The promise of retinoids to fight against cancer", Nature Reviews Cancer, vol. 1, no. 3, pp. 181-193, 2001.
34. Siddikuzzaman, C. Guruvayoorappan, and V. M. Berlin Grace, "All trans retinoic acid and cancer", Immunopharmacology and Immunotoxicology, vol. 33, no. 2, pp. 241-249, 2011.
35. R. M. Niles, "Vitamin A and cancer", Nutrition, vol. 16, no. 7-8, pp. 573-576, 2000.
36. O. Arrieta, C. H. González-De La Rosa, E. Aréchaga-Ocampo et al., "Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as firstline treatment in patients with advanced non-small-cell lung cancer", Journal of Clinical Oncology, vol. 28, no. 21, pp. 3463-3471, 2010.
37. M. Bryan, E. D. Pulte, K. C. Toomey et al., "A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer", Investigational New Drugs, vol. 29, no. 6, pp. 1482-1487, 2011.
38. L. K. Hillestad, "Acute promyelocytic leukemia", Acta Medica Scandinavica, vol. 159, no. 3, pp. 189-194, 1957.
39. J. D. Rowley, H. M. Golomb, and C. Dougherty, "15/17 Translocation, a consistent chromosomal change in acute promyelocytic leukaemia", The Lancet, vol. 1, no. 8010, pp. 549-550, 1977.
40. A. Kakizuka, W. H. Miller Jr., K. Umesono et al., "Chromosomal translocation t (15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML", Cell, vol. 66, no. 4, pp. 663-674, 1991.
41. H. DeThé, C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean, "The PML-RARα fusion mRNA generated by the t (15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR", Cell, vol. 66, no. 4, pp. 675-684, 1991.
42. J. Borrow, A. D. Goddard, D. Sheer, and E. Solomon, "Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17", Science, vol. 249, no. 4976, pp. 1577-1580, 1990.
43. J. A. Dyck, G. G. Maul, W. H. Miller Jr., J. D. Chen, A. Kakizuka, and R. M. Evans, "A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein", Cell, vol. 76, no. 2, pp. 333-343, 1994.
44. R. Bernardi and P. P. Pandolfi, "Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies", Nature Reviews Molecular Cell Biology, vol. 8, no. 12, pp. 1006-1016, 2007.
45. S. Dong, J.-P. Geng, J.-H. Tong et al., "Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary structure of the reciprocal products of the PML-RARA gene in a patient with t (15;17)", Genes Chromosomes & Cancer, vol. 6, no. 3, pp. 133-139, 1993.
46. A. Melnick and J. D. Licht, "Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia", Blood, vol. 93, no. 10, pp. 3167-3215, 1999.
47. L. Di Croce, V. A. Raker, M. Corsaro et al., "Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor", Science, vol. 295, no. 5557, pp. 1079-1082, 2002.
48. R. Nasr, M.-C. Guillemin, O. Ferhi et al., "Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation", Nature Medicine, vol. 14, no. 12, pp. 1333-1342, 2008.
49. S. Kitareewan, I. Pitha-Rowe, D. Sekula et al., "UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia", Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3806-3811, 2002.
50. Y. Huang, J. Qiu, G. Chen, and S. Dong, "Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARα, resulting in sequestration and decreased mobility of SMRT", Biochemical and Biophysical Research Communications, vol. 365, no. 2, pp. 258-265, 2008.
51. P. Isakson, M. Bjørås, S. O. Bøe, and A. Simonsen, "Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein", Blood, vol. 116, no. 13, pp. 2324-2331, 2010.
52. N. Bushue and Y.-J. Y. Wan, "Retinoid pathway and cancer therapeutics", Advanced Drug Delivery Reviews, vol. 62, no. 13, pp. 1285-1298, 2010.
53. F. Lo-Coco, G. Avvisati, M. Vignetti et al., "Front-line treatment of acute promyelocytic leukemia with AIDAinduction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group", Blood, vol. 116, no. 17, pp. 3171-3179, 2010.
54. F. Lo-Coco, G. Avvisati, M. Vignetti et al., "Retinoic acid and arsenic trioxide for acute promyelocytic leukemia", The New England Journal of Medicine, vol. 369, no. 2, pp. 111-121, 2013.
55. Z.-Y. Wang and Z. Chen, "Acute promyelocytic leukemia: from highly fatal to highly curable", Blood, vol. 111, no. 5, pp. 2505-2515, 2008.
56. R. C. Moon, C. J. Grubbs, and M. B. Sporn, "Inhibition of 7, 12 dimethylbenz (a) anthracene induced mammary carcinogenesis by retinyl acetate", Cancer Research, vol. 36, no. 7, part 2, pp. 2626-2630, 1976.
57. Z. Zhao, Z.-P. Zhang, D. R. Soprano, and K. J. Soprano, "Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells", Experimental Cell Research, vol. 219, no. 2, pp. 555-561, 1995.
58. M. P. Ribeiro, A. E. Santos, and J. B. Custodio, "Interplay between estrogen and retinoid signaling in breast cancer. current and future perspectives", Cancer Letters, vol. 353, no. 1, pp. 17-24, 2014.
59. M. S. Sheikh, Z.-M. Shao, J.-C. Chen, A. Hussain, A. M. Jetten, and J. A. Fontana, "Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid", Journal of Cellular Biochemistry, vol. 53, no. 4, pp. 394-404, 1993.
60. M. S. Sheikh, Z.-M. Shao, X.-S. Li et al., "Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-α acquire sensitivity to growth inhibition by retinoids", The Journal of Biological Chemistry, vol. 269, no. 34, pp. 21440-21447, 1994.
61. N. Clarke, P. Germain, L. Altucci, and H. Gronemeyer, "Retinoids: potential in cancer prevention and therapy", Expert Reviews in Molecular Medicine, vol. 6, no. 25, pp. 1-23, 2004.
62. Q. Wang, D. Lee, V. Sysounthone et al., "1, 25-Dihydroxyvitamin D 3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects", Breast Cancer Research and Treatment, vol. 67, no. 2, pp. 157-168, 2001.
63. A. R. Mawson, "Retinoids in the treatment of glioma: a new perspective", Cancer Management and Research, vol. 4, no. 1, pp. 233-241, 2012.
64. M.-A. Shibata, M. Hirose, A. Masuda, T. Kato, M. Mutai, and N. Ito, "Modification of BHA forestomach carcinogenesis in rats: inhibition by diethylmaleate or indomethacin and enhancement by a retinoid", Carcinogenesis, vol. 14, no. 7, pp. 1265-1269, 1993.
65. A. E. Rogers, B. J. Herndon, and P. M. Newberne, "Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A.", Cancer Research, vol. 33, no. 5, pp. 1003-1009, 1973.
66. S. Han, T. Fukazawa, T. Yamatsuji et al., "Anti-tumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and Retinoic acids", PLoS ONE, vol. 5, no. 11, Article ID e13834, 2010.
67. N. Hail Jr., H. J. Kim, and R. Lotan, "Mechanisms of fenretinideinduced apoptosis", Apoptosis, vol. 11, no. 10, pp. 1677-1694, 2006.
68. H. Abou-Issa, M. Moeschberger, W. Ei-Masry, S. Tejwani, R. W. Curley Jr., and T. E. Webb, "Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis", Anticancer Research, vol. 15, no. 3, pp. 805-810, 1995.
69. S. M. I. Kazmi, R. K. Plante, V. Visconti, and C. Y. Lau, "Comparison of N- (4-hydroxyphenyl) retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines", Cancer Research, vol. 56, no. 5, pp. 1056-1062, 1996.
70. R. C. Moon, J. F. Pritchard, R. G. Mehta, C. T. Nomides, C. F. Thomas, and N. M. Dinger, "Suppression of rat mammary cancer development by N- (4-hydroxyphenyl) retinamide (4-HPR) following surgical removal of first palpable tumor", Carcinogenesis, vol. 10, no. 9, pp. 1645-1649, 1989.
71. M. Pollard, P. H. Luckert, and M. B. Sporn, "Prevention of primary prostate cancer in Lobund-Wistar rats by N- (4-hydroxyphenyl) retinamide", Cancer Research, vol. 51, no. 13, pp. 3610-3611, 1991.
72. D. L. McCormick, P. J. Becci, and R. C. Moon, "Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2)", Carcinogenesis, vol. 3, no. 12, pp. 1473-1477, 1982.
73. D. L. McCormick and R. C. Moon, "Antipromotional activity of dietary N- (4-hydroxyphenyl) retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice", Cancer Letters, vol. 31, no. 2, pp. 133-138, 1986.
74. T.-C. Hsieh, C. Ng, and J. M. Wu, "The synthetic retinoid N- (4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells", Biochemistry and Molecular Biology International, vol. 37, no. 3, pp. 499-506, 1995.
75. Y. Ziv, M. K. Gupta, J. W. Milsom, A. Vladisavljevic, M. Brand, and V. W. Fazio, "The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro", Anticancer Research, vol. 14, no. 5 A, pp. 2005-2009, 1994.
76. N. Oridate, D. Lotan, M. F. Mitchell, W. K. Hong, and R. Lotan, "Induction of apoptosis by retinoids in human cervical carcinoma cell lines", International Journal of Oncology, vol. 7, no. 3, pp. 433-441, 1995.
77. R. Supino, M. Crosti, and M. Clerici, "Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression", International Journal of Cancer, vol. 65, no. 4, pp. 491-497, 1996.
78. F. Formelli and L. Cleris, "Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity", Cancer Research, vol. 53, no. 22, pp. 5374-5376, 1993.
79. J. G. Villablanca, W. B. London, A. Naranjo et al., "Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the children's oncology group", Clinical Cancer Research, vol. 17, no. 21, pp. 6858-6866, 2011.
80. G. P. Kalemkerian, R. Slusher, S. Ramalingam, S. Gadgeel, and M. Mabry, "Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines", Journal of the National Cancer Institute, vol. 87, no. 22, pp. 1674-1680, 1995.
81. C.-H. Ohlmann, C. Jung, and G. Jaques, "Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N- (4-hydroxyphenyl) retinamide] sufficient for cancer therapy?" International Journal of Cancer, vol. 100, no. 5, pp. 520-526, 2002.
82. C. P. Reynolds, Y. Wang, L. J. Melton, P. A. Einhorn, D. J. Slamon, and B. J. Maurer, "Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide", Medical and Pediatric Oncology, vol. 35, no. 6, pp. 597-602, 2000.
83. A. Di Vinci, E. Geido, E. Infusini, and W. Giaretti, "Neuroblastoma cell apoptosis induced by the synthetic retinoid N- (4-hydroxyphenyl) retinamide", International Journal of Cancer, vol. 59, no. 3, pp. 422-426, 1994.
84. A. Mariotti, E. Marcora, G. Bunone et al., "N- (4-hydroxyphenyl) retinamide: a potent inducer of apoptosis in human neuroblastoma cells", Journal of the National Cancer Institute, vol. 86, no. 16, pp. 1245-1247, 1994.
85. D. Delia, A. Aiello, L. Lombardi et al., "N- (4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid", Cancer Research, vol. 53, no. 24, pp. 6036-6041, 1993.
86. B. Ozpolat, A. M. Tari, K. Mehta, and G. Lopez-Berestein, "Nuclear retinoid receptors are involved in N- (4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells", Leukemia and Lymphoma, vol. 45, no. 5, pp. 979-985, 2004.
87. B. J. Maurer, L. S. Metelitsa, R. C. Seeger, M. C. Cabot, and C. P. Reynolds, "Increase of ceramide and induction of mixed apoptosis/necrosis by N- (4-hydroxyphenyl)-retinamide in neuroblastoma cell lines", Journal of the National Cancer Institute, vol. 91, no. 13, pp. 1138-1146, 1999.
88. A. Asumendi, M. C. Morales, A. Alvarez, J. Aréchaga, and G. Pérez-Yarza, "Implication of mitochondria-derived ROS and cardiolipin peroxidation in N- (4-hydroxyphenyl) retinamideinduced apoptosis", British Journal of Cancer, vol. 86, no. 12, pp. 1951-1956, 2002.
89. A. Erdreich-Epstein, L. B. Tran, N. N. Bowman et al., "Ceramide signaling in fenretinide-induced endothelial cell apoptosis", The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49531-49537, 2002.
90. H. Wang, B. J. Maurer, Y. Y. Liu et al., "N- (4-Hydroxyphenyl) retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing", Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2967-2976, 2008.
91. B. J. Maurer, L. Melton, C. Billups, M. C. Cabot, and C. P. Reynolds, "Synergistic cytotoxicity in solid tumor cell lines between N- (4-hydroxyphenyl) retinamide and modulators of ceramide metabolism", Journal of the National Cancer Institute, vol. 92, no. 23, pp. 1897-1909, 2000.
92. M. L. Villa, E. Ferrario, D. Trabattoni et al., "Retinoids, breast cancer and NK cells", British Journal of Cancer, vol. 68, no. 5, pp. 845-850, 1993.
93. Z. Zhao, T. Matsuura, K. Popoff, and A. C. Ross, "Effects of N- (4-hydroxyphenyl)-retinamide on the number and cytotoxicity of natural killer cells in vitamin-A-sufficient and -deficient rats", Natural Immunity, vol. 13, no. 5, pp. 280-288, 1994.
94. D. Ribatti, G. Alessandri, M. Baronio et al., "Inhibition of neuroblastoma-induced angiogenesis by fenretinide", International Journal of Cancer, vol. 94, no. 3, pp. 314-321, 2001.
95. T. Okusaka, H. Ueno, M. Ikeda, Y. Takezako, and C. Morizane, "Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma", Cancer Science, vol. 103, no. 8, pp. 1524-1530, 2012.
96. N. Minagawa, Y. Nakayama, Y. Inoue et al., "4-[3, 5-Bis (trimethylsilyl) benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor", Oncology Research, vol. 14, no. 9, pp. 407-414, 2004.
97. C. R. Schadt, "Topical and oral bexarotene", Dermatologic Therapy, vol. 26, no. 5, pp. 400-403, 2013.
98. B. Das, H. Yeger, R. Tsuchida et al., "A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1α throughmitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma", Cancer Research, vol. 65, no. 16, pp. 7267-7275, 2005.
99. A. Orlandi, L. Bianchi, A. Costanzo, E. Campione, L. G. Spagnoli, and S. Chimenti, "Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene", Journal of Investigative Dermatology, vol. 122, no. 4, pp. 1037-1041, 2004.
100. L. Bianchi, A. Orlandi, E. Campione et al., "Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases", The British Journal of Dermatology, vol. 151, no. 1, pp. 148-156, 2004.
101. A. P. Chou, R. Chowdhury, S. Li et al., "Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas", Journal of the National Cancer Institute, vol. 104, no. 19, pp. 1458-1469, 2012.
102. J. L. Napoli, "Retinoic acid biosynthesis and metabolism", The FASEB Journal, vol. 10, no. 9, pp. 993-1001, 1996.
103. M. H. E. M. Boerman and J. L. Napoli, "Cellular retinol-binding protein-supported retinoic acid synthesis: relative roles of microsomes and cytosol", The Journal of Biological Chemistry, vol. 271, no. 10, pp. 5610-5616, 1996.
104. M. Sundaram, A. Sivaprasadarao, D. M. F. van Aalten, and J. B. C. Findlay, "Expression, characterization and engineered specificity of rat epididymal retinoic acid-binding protein", Biochemical Journal, vol. 334, no. 1, pp. 155-160, 1998.
105. A.-L. Gustafson, L. Dencker, and U. Eriksson, "Non-overlapping expression of CRBP I and CRABP I during pattern formation of limbs and craniofacial structures in the early mouse embryo", Development, vol. 117, no. 2, pp. 451-460, 1993.
106. N. B. Ghyselinck, C. Båvik, V. Sapin et al., "Cellular retinolbinding protein I is essential for vitamin A homeostasis", The EMBO Journal, vol. 18, no. 18, pp. 4903-4914, 1999.
107. J. E. Dowling and G. Wald, "Vitamin A deficiency and night blindness", Proceedings of the National Academy of Sciences of the United States of America, vol. 44, no. 7, pp. 648-661, 1958.
108. F. M. Herr and D. E. Ong, "Differential interaction of lecithinretinol acyltransferase with cellular retinol binding proteins", Biochemistry, vol. 31, no. 29, pp. 6748-6755, 1992.
109. M. Mark, N. B. Ghyselinck, and P. Chambon, "Function of retinoic acid receptors during embryonic development", Nuclear Receptor Signaling, vol. 7, article e002, 2009.
110. L. Tannous-Khuri and D. A. Talmage, "Decreased cellular retinolbinding protein expression coincideswith the loss of retinol responsiveness in rat cervical epithelial cells", Experimental Cell Research, vol. 230, no. 1, pp. 38-44, 1997.
111. P. Hillemanns, L. Tannous-Khuri, J. P. Koulos, D. Talmage, and T. C. Wright Jr., "Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma", The American Journal of Pathology, vol. 141, no. 4, pp. 973-980, 1992.
112. A. Orlandi, A. Ferlosio, A. Ciucci et al., "Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications", Histopathology, vol. 45, no. 5, pp. 511-517, 2004.
113. G. Xu, M.-L. Bochaton-Piallat, D. Andreutti, R. B. Low, G. Gabbiani, and P. Neuville, "Regulation of α-smooth muscle actin and CRBP-1 expression by retinoic acid and TGF-β in cultured fibroblasts", Journal of Cellular Physiology, vol. 187, no. 3, pp. 315-325, 2001.
114. G. Xu, M. Redard, G. Gabbiani, and P. Neuville, "Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs", The American Journal of Pathology, vol. 151, no. 6, pp. 1741-1749, 1997.
115. K. Uchio, B. Tuchweber, N. Manabe, G. Gabbiani, J. Rosenbaum, and A. Desmoulière, "Cellular retinol-binding protein-1 expression andmodulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts", Laboratory Investigation, vol. 82, no. 5, pp. 619-628, 2002.
116. R. Blomhoff, K. R. Norum, and T. Berg, "Hepatic uptake of [3H]retinol bound to the serumretinol binding protein involves both parenchymal and perisinusoidal stellate cells", The Journal of Biological Chemistry, vol. 260, no. 25, pp. 13571-13575, 1985.
117. R. Blomhoff, M. H. Green, T. Berg, and K. R. Norum, "Transport and storage of vitamin A", Science, vol. 250, no. 4979, pp. 399-404, 1990.
118. P. Neuville, A. Geinoz, G. Benzonana et al., "Cellular retinolbinding protein-1 is expressed by distinct subsets of rat arterial smoothmuscle cells in vitro and in vivo", The American Journal of Pathology, vol. 150, no. 2, pp. 509-521, 1997.
119. M. A. Schwartz, M. D. Schaller, and M. H. Ginsberg, "Integrins: emerging paradigms of signal transduction", The Annual Review of Cell and Developmental Biology, vol. 11, pp. 549-599, 1995.
120. D. Cvetković, S. J. Williams, and T. C. Hamilton, "Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer", Clinical Cancer Research, vol. 9, no. 3, pp. 1013-1020, 2003.
121. Y. S. Kuppumbatti, I. J. Bleiweiss, J. P. Mandeli, S. Waxman, and R. Mira-Y-Lopez, "Cellular retinol-binding protein expression and breast cancer", Journal of the National Cancer Institute, vol. 92, no. 6, pp. 475-480, 2000.
122. A. Orlandi, A. Ferlosio, A. Ciucci et al., "Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications", Modern Pathology, vol. 19, no. 6, pp. 797-803, 2006.
123. M. Esteller, M. Guo, V. Moreno et al., "Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer", Cancer Research, vol. 62, no. 20, pp. 5902-5905, 2002.
124. D. H. Lee and A. L. Goldberg, "Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae", The Journal of Biological Chemistry, vol. 271, no. 44, pp. 27280-27284, 1996.
125. L. H. Ellenson and T.-C. Wu, "Focus on endometrial and cervical cancer", Cancer Cell, vol. 5, no. 6, pp. 533-538, 2004.
126. C. Jerónimo, R. Henrique, J. Oliveira et al., "Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer", Journal of Clinical Pathology, vol. 57, no. 8, pp. 872-876, 2004.
127. E. Doldo, G. Costanza, A. Ferlosio et al., "CRBP-1 expression in ovarian cancer: a potential therapeutic target", Anticancer Research, vol. 34, no. 7, pp. 3303-3312, 2014.
128. M. Mendoza-Rodriguez, H. Arreola, A. Valdivia et al., "Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer", International Journal of Clinical and Experimental Pathology, vol. 6, no. 9, pp. 1817-1825, 2013.
129. R. Peralta, M. Baudis, G. Vazquez et al., "Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma", Journal of Cancer Research and Clinical Oncology, vol. 136, no. 6, pp. 931-938, 2010.
130. J. Kwong, K.-W. Lo, L. S.-N. Chow et al., "Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma", Neoplasia, vol. 7, no. 1, pp. 67-74, 2005.
131. E. J. Morris, J. C. Dreixler, K.-Y. Cheng, P. M. Wilson, R. M. Gin, and H. M. Geller, "Optimization of single-cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage", Bio Techniques, vol. 26, no. 2, pp. 282-289, 1999.
132. A. Schmitt-Gräff, V. Ertelt, H.-P. Allgaier et al., "Cellular retinolbinding protein-1 in hepatocellular carcinoma correlates with β-catenin, Ki-67 index, and patient survival", Hepatology, vol. 38, no. 2, pp. 470-480, 2003.
133. J. Behrens, L. Vakaet, R. Friis et al., "Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene", Journal of Cell Biology, vol. 120, no. 3, pp. 757-766, 1993.
134. N. A. C. S. Wong and M. Pignatelli, "β-catenin-a linchpin in colorectal carcinogenesis?" The American Journal of Pathology, vol. 160, no. 2, pp. 389-401, 2002.
135. M. Husmann, B. Hoffmann, D. G. Stump, F. Chytil, and M. Pfahl, "A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer", Biochemical and Biophysical Research Communications, vol. 187, no. 3, pp. 1558-1564, 1992.
136. E. Garattini, M. Bolis, S. K. Garattini et al., "Retinoids andbreast cancer: from basic studies to the clinic and back again", Cancer Treatment Reviews, vol. 40, no. 6, pp. 739-749, 2014.
137. E. F. Farias, C. Marzan, and R. Mira-Y-Lopez, "Cellular retinolbindmg protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization", Oncogene, vol. 24, no. 9, pp. 1598-1606, 2005.
138. L. Campagnolo, G. Costanza, A. Francesconi, G. Arcuri, I. Moscatelli, and A. Orlandi, "Sortilin expression is essential for pro-nerve growth factor-induced apoptosis of rat vascular smoothmuscle cells", PLoS ONE, vol. 9, no. 1, Article IDe84969, 2014.
139. A. Yasmeen, M.-C. Beauchamp, E. Piura, E. Segal, M. Pollak, and W. H. Gotlieb, "Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins", Gynecologic Oncology, vol. 121, no. 3, pp. 492-498, 2011.
140. C. Valerio, M. G. Scioli, P. Gentile et al., "Platelet-rich plasma greatly potentiates insulin-induced adipogenic differentiation of human adipose-derived stem cells through a serine/threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenance", Stem Cells Translational Medicine, vol. 1, no. 3, pp. 206-220, 2012.
141. M. Heuser, L. M. Sly, B. Argiropoulos et al., "Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal", Blood, vol. 114, no. 19, pp. 3983-3993, 2009.
142. P. J. Roberts and C. J. Der, "Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer", Oncogene, vol. 26, no. 22, pp. 3291-3310, 2007.
143. E. F. Farias, D. E. Ong, N. B. Ghyselinck, S. Nakajo, Y. S. Kuppumbatti, and R. M. Lopez, "Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity", Journal of the National Cancer Institute, vol. 97, no. 1, pp. 21-29, 2005.